Company
United StatesPublic company, NASDAQ: LINLinde Inc (NASDAQ: LIN), Memphis, TN – FDA Inspections
Inspection records and compliance data for Linde Inc in Memphis, Tennessee. 3 FDA inspections on record, last inspected September 30, 2014. Publicly traded as NASDAQ: LIN.
Company Profile
This profile covers Linde Inc based in Memphis, Tennessee, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 0
- NAI
- 3
- Form 483s
- 0
- Warning letters
- 0
First inspected April 30, 2010. Last inspected September 30, 2014.
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| September 30, 2014 | NAI | Human Drugs · Drug Quality Assurance | 898316 |
| July 6, 2011 | NAI | Human Drugs · Drug Quality Assurance | 733460 |
| April 30, 2010 | NAI | Human Drugs · Drug Quality Assurance | 663586 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Linde Inc
Stock ticker
LIN
Exchange
NASDAQ
Share price
$521.47
Market cap
$239.4B
Price as of
November 6, 2026
FEI Number
3001237674
Address
3587 Paul R Lowry Rd, Memphis, Tennessee 38109, United States
Country
United States
ID: 75f916e2-7568-49ed-ab0a-48b6018b9b4d